Nigel Theobald
Fondatore presso N4 PHARMA PLC
Patrimonio netto: 135 171 $ in data 31/05/2024
Profilo
Nigel James Theobald is the founder of Abaco Capital Plc (founded in 2009), N4 Pharma Ltd.
(founded in 2014), and N4 Pharma Plc (founded in 2014).
At N4 Pharma Ltd., he held the title of Chief Executive Officer, and at N4 Pharma Plc, he held the title of Chief Executive Officer & Executive Director.
Mr. Theobald's former jobs include Non-Executive Director at Medherant Ltd.
and Head-Healthcare Brands at Boots Group Plc.
Mr. Theobald received an undergraduate degree from The University of Southampton.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
N4 PHARMA PLC
6.32% | 13/06/2024 | 16 981 319 ( 6.32% ) | 135 171 $ | 31/05/2024 |
Posizioni attive di Nigel Theobald
| Società | Posizione | Inizio |
|---|---|---|
| N4 PHARMA PLC | Fondatore | 01/01/2014 |
Precedenti posizioni note di Nigel Theobald
| Società | Posizione | Fine |
|---|---|---|
Boots Group Plc
 Boots Group Plc Pharmaceuticals: MajorHealth Technology Boots Group Plc retails chemists' merchandise and auto parts; provision of opticians' and other healthcare services; development, manufacture and marketing of healthcare and consumer products | Corporate Officer/Principal | - |
N4 Pharma Ltd.
 N4 Pharma Ltd. Pharmaceuticals: GenericHealth Technology N4 Pharma Ltd. operates as a drug reformulation company. The firm focuses on developing and out licensing new versions of existing and novel high value drugs with an unmet commercial or medical need. Its proprietary platform technologies include: Cocrys which is a process able to use hot melt extrusion to produce co-crystals of drugs; and Nuvac which is a nano-carrier delivery system for antigens that improves both humoral and cell mediation effects for vaccines. The company was founded by Nigel James Theobald in 2014 and is headquartered in Chellaston, the United Kingdom. | Amministratore Delegato | - |
Medherant Ltd.
 Medherant Ltd. Pharmaceuticals: MajorHealth Technology Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom. | Direttore/Membro del Consiglio | - |
| ABACO CAPITAL PLC | Fondatore | - |
Formazione di Nigel Theobald
| The University of Southampton | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| N4 PHARMA PLC | Health Technology |
| Aziende private | 4 |
|---|---|
Abaco Capital Plc
 Abaco Capital Plc Financial ConglomeratesFinance Abaco Capital Plc was a drug development company, which was engaged in re-developing approved drugs using proprietary formulation technologies. The company was founded by Marcelo Bravo and Nigel Theobald on October 7, 2009 and was headquartered in London, the United Kingdom. | Finance |
N4 Pharma Ltd.
N4 Pharma Ltd. Pharmaceuticals: GenericHealth Technology N4 Pharma Ltd. operates as a drug reformulation company. The firm focuses on developing and out licensing new versions of existing and novel high value drugs with an unmet commercial or medical need. Its proprietary platform technologies include: Cocrys which is a process able to use hot melt extrusion to produce co-crystals of drugs; and Nuvac which is a nano-carrier delivery system for antigens that improves both humoral and cell mediation effects for vaccines. The company was founded by Nigel James Theobald in 2014 and is headquartered in Chellaston, the United Kingdom. | Health Technology |
Medherant Ltd.
Medherant Ltd. Pharmaceuticals: MajorHealth Technology Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom. | Health Technology |
Boots Group Plc
Boots Group Plc Pharmaceuticals: MajorHealth Technology Boots Group Plc retails chemists' merchandise and auto parts; provision of opticians' and other healthcare services; development, manufacture and marketing of healthcare and consumer products | Health Technology |
- Borsa valori
- Insiders
- Nigel Theobald
